Monograph
N06BX03 - Piracetam |
Propably not porphyrinogenic |
PNP |
Rationale
Not metabolised.
Chemical description
GABA derivative (oxipyrridylacetamide) used against cortical myoclonus. Not metabolized, rapidly eliminated in unchanged form by the kidneys. French list: use
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Nootropil 1200, 1200 mg filmomhulde tabletten · Piracetam 800 mg Teva, tabletten 
Nootropil 1 200 mg compr. pellic. · Nootropil 20 % sol. buv. · Nootropil 33 % sol. buv. · Nootropil 800 mg compr. pellic. · Piracetam EG 1 200 mg compr. pellic. · Piracetam EG 800 mg compr. pellic. · Piracetam-UCB 1 200 mg compr. pellic. 
CICLOFALINA 800 mg COMPRIMIDOS RECUBIERTOS CON PELICULA · CICLOFALINA 800 mg POLVO PARA SOLUCION ORAL · Nootropil 
MEMOTAL1 g/5 ml · NOOTROPIL 800 mg · PIRACETAM HELCOR 400mg · PIRACETAM HELCOR 800mg · PIRACETAM 400 mg · PIRACETAM ARENA 400 mg · PIRACETAM FARMEX 400 mg · PIRACETAM LAROPHARM 400 mg · PIRACETAM MCC 400 mg · PIRACETAM SINTOFARM 400 mg · PIRACETAM SLAVIA 400 mg · PIRACETAM-AC 400 mg · PIRACETAM-AC 800 mg · PIRACETAM-RICHTER 400 mg 
Nootropil · Piracetam 
Nootropil · Piracetam 
Biotropil 1200 · Biotropil 800 · Lucetam · MemoniQ · Memotropil · Memotropil 20% · Nootropil · Nootropil 20% · Nootropil 33% · Piracetam Espefa · Piracetam Polpharma · Recodium · Recodium max 
Nootropil · Nootropil-1200 · Nootropil-800 · Piracetam eg · Piracetam-eg · Piracetam-Ratiopharm-1200 · Piracetam-Ratiopharm-800 · Piracetam-ucb 
Nootropil 
Lucetam · Nootropil · Piracetam Olpha · Piracetam-Kalceks
© NAPOS 2025